원문정보
피인용수 : 0건 (자료제공 : 네이버학술정보)
초록
영어
I will discuss about our preclinical data of anti-KDR neutralizing fully human IgG1, Tanibirumab which has cross-species cross reactivity, and about our recent progress from dual target neutralizing multifunctional Ig like next generation protein therapeutics, DIG-KT (KDR &Tie2) from DIG-bodies platform, and PIG-KM (KDR &cMET) from PIG-bodies platform.
저자정보
참고문헌
자료제공 : 네이버학술정보